OptiMAX expands the range of the Optima Coil System
As an extension of the Optima family, the optiMAX Coil received CE approval in May 2021. The optiMAX Coils deliver the same characteristics in terms of stability and reliability as already known from the established Optima family. The system is approved for endovascular use for occlusion of peripheral as well as intracranial vascular anomalies. The primary winding of the optiMAX has been increased by up to .004" compared to Optima, resulting in a higher packing density with the same number of coils used.
HERE you can find more information about the new optiMAX coil by BALT!